<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors></authors><secondary-authors><author><style face="normal" font="default" size="100%">Grimm, Richard H.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Results from the ACCORD BP Trial</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-14</style></pages><abstract><style  face="normal" font="default" size="100%">Intensive blood pressure (BP) control did not reduce the rate of a composite outcome of major cardiovascular events in high-risk patients with type 2 diabetes mellitus, according to the Action to Control Cardiovascular Risk in Diabetes [ACCORD; NCT00000620] BP Trial. However, intensive BP control correlated with reductions in the rate of total stroke and nonfatal stroke.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>